Form 4 for AXGN Axogen, Inc.
Accepted 2022-03-18 00:00:00 ET · period of report 2022-03-16 · accession 0000805928-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-18 | 2022-03-16 | AXGN | MARIANI PETER J | EVP, CFO | F - Tax | $7.97 | -2,769 | 34.6K | -7% | -$22.1K |
| D | 2022-03-18 | 2022-03-16 | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $0.00 | +11.0K | 37.4K | +42% | $0 |
| D | 2022-03-18 | 2022-03-16 | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $0.00 | -11.0K | 11.0K | -50% | $0 |
| DM | 2022-03-18 | 2022-03-16 | AXGN | MARIANI PETER J | EVP, CFO | A - Grant | $0.00 | +179.9K | 103.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-16 | F | D | 2,769 | $7.97 | 34,584 | D | — | — | (F2) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| 2 | Common | Common Stock | 2022-03-16 | M | A | 11,000 | $0.00 | 37,353 | D | — | — | (F1) This reflects the number of restricted stock units that became vested as of March 16, 2022. |
| 3 | Derivative | Restricted Stock Units | 2022-03-16 | M | D | 11,000 | $0.00 | 11,000 | D | — · — to — | 11,000 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. (F4) All shares of Axogen Inc. common stock underlying the restricted stock Units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |
| 4 | Derivative | Restricted Stock Units | 2022-03-16 | A | A | 76,780 | $0.00 | 76,780 | D | — · — to — | 76,780 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock. (F5) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |
| 5 | Derivative | Employee Stock Option (right to purchase) | 2022-03-16 | A | A | 103,079 | $0.00 | 103,079 | D | $10.25 · — to 2032-03-16 | 103,079 Common Stock | (F6) The exercise price of $10.25 represents a 25% premium over the fair market value of Axogen common stock on the date of the grant. (F7) All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 16, 2023 and on each anniversary thereafter. |